![\"free](\"//sstatic1.histats.com/0.gif?5052552&101\")
How many companies are in the NBI?
William Howard 
At the time of writing, the NBI index currently sits at 4,064 and is comprised of 206 securities. It is run by NASDAQ Global Indexes. Pfizer (PFE), Eli Lilly (LLY), Merck (MRK), and Johnson & Johnson (JNJ) are not in the index because they are all NYSE-listed and therefore not eligible for inclusion.
How many companies are in the Nasdaq Biotech index?
ICB currently classifies 230 companies as Biotechnology and the remaining 44 as Pharmaceuticals.
Is NBI market cap weighted?
The Index is a modified market capitalization-weighted index. NBI employs a two-stage weight adjustment scheme. Index Securities’ initial weights are determined by dividing each Index Security’s market capitalization by the aggregate market capitalization of all Index Securities.
What stocks are in the IBB ETF?
Top 10 Holdings (50.97% of Total Assets)
| Name | Symbol | % Assets |
|---|---|---|
| Moderna Inc | MRNA | 9.07% |
| Amgen Inc | AMGN | 7.73% |
| Gilead Sciences Inc | GILD | 6.42% |
| Illumina Inc | ILMN | 5.41% |
What companies are in the biotech index?
Top 30 Components
| Symbol | Company Name | Last Price |
|---|---|---|
| TWST | Twist Bioscience Corporation | 96.69 |
| LEGN | Legend Biotech Corporation | 53.21 |
| BLUE | bluebird bio, Inc. | 10.73 |
| MRNA | Moderna, Inc. | 276.38 |
How many public biotech companies are there?
As of March 2021, there were over 620 biopharma companies listed on the NASDAQ and NYSE, according to BMO Capital Markets.
How is NBI calculated?
What are the top 10 holdings in IBB?
How many biotech companies went public in 2020?
Thirteen biotechs
Thirteen biotechs with genetic medicine technologies went public in 2020, nearly as many as the previous two years combined. Another 13 have already gone public in 2021, with six months still to go. Four of the year’s top performers are developing gene-based treatments, led by CRISPR biotech Verve Therapeutics.
